Tuberculosis treatment intermittency in the continuation phase and mortality in HIV-positive persons receiving antiretroviral therapy

BACKGROUND: Some tuberculosis (TB) treatment guidelines recommend daily TB treatment in both the intensive and continuation phases of treatment in HIV-positive persons to decrease the risk of relapse and acquired drug resistance. However, guidelines vary across countries, and treatment is given 7, 5...

Descripción completa

Detalles Bibliográficos
Autores principales: Crabtree-Ramirez, Brenda, Jenkins, Cathy A., Shepherd, Bryan E., Jayathilake, Karu, Veloso, Valdilea G., Carriquiry, Gabriela, Gotuzzo, Eduardo, Cortes, Claudia P., Padgett, Dennis, McGowan, Catherine, Sierra-Madero, Juan, Koenig, Serena, Pape, Jean W., Sterling, Timothy R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985331/
https://www.ncbi.nlm.nih.gov/pubmed/35382770
http://dx.doi.org/10.1186/s12879-022-07330-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8985331/
https://www.ncbi.nlm.nih.gov/pubmed/35382770
http://dx.doi.org/10.1186/s12879-022-07330-5

Ejemplares similares